Clinical Trial Update: Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of genistein for stage II–IV prostate cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: WITHDRAWN